Cases 11 - 20 of 45
Pfizer Inc. et al v. Cipla, Ltd. et al
as 1:2020cv01393
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Defendant:
Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Cipla Limited et al
as 1:2020cv00977
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. Cipla Limited et al
as 1:2019cv02210
Defendant:
Cipla Limited and Cipla USA Inc.
Plaintiff:
Biogen International GmbH
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Cipla Limited et al
as 1:2019cv02085
Plaintiff:
ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Cipla Limited et al
as 1:2019cv01494
Defendant:
Cipla USA, Inc. and Cipla Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
Pfizer Inc. et al. v. Cipla USA Inc. et al.
as 1:2019cv00749
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00733
Defendant:
AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
